Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for prevention of depression in patients with multiple sclerosis
IRCT2015090723927N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by Tabriz University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT2015090723927N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015090723927N1.